Article Versions Notes

Yabe M, Omarbekova AZ, Hsu M, May H, Arcila ME, Liu Y, Dogan A, Brunner AM, Nardi V, Hasserjian RP, et al. TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes. Cancers. 2021; 13(21):5502. https://doi.org/10.3390/cancers13215502

Yabe, Mariko, Aidana Z. Omarbekova, Meier Hsu, Hannah May, Maria E. Arcila, Ying Liu, Ahmet Dogan, Andrew M. Brunner, Valentina Nardi, Robert P. Hasserjian, and et al. 2021. "TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes" Cancers 13, no. 21: 5502. https://doi.org/10.3390/cancers13215502

Yabe, M., Omarbekova, A. Z., Hsu, M., May, H., Arcila, M. E., Liu, Y., Dogan, A., Brunner, A. M., Nardi, V., Hasserjian, R. P., & Klimek, V. M. (2021). TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes. Cancers, 13(21), 5502. https://doi.org/10.3390/cancers13215502